Stage IV NSCLC

9 registered clinical trials studyying Stage IV NSCLC — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Can NCT06671613	VA Office of Research and Development	N/A
Withdrawn	Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC NCT06064279	VA Office of Research and Development	Phase 1 / Phase 2
Not Yet Recruiting	Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib NCT05988697	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	—
Terminated	Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancr NCT05631574	Biomea Fusion Inc.	Phase 1
Completed	Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients NCT03812549	Sichuan University	Phase 1
Completed	Combination of Metformin With Gefitinib to Treat NSCLC NCT01864681	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Phase 2
Unknown	The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial NCT03402048	University of Turin, Italy	Phase 3
Terminated	Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer NCT01640730	KangLaiTe USA	Phase 2
Completed	Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer NCT01438307	University of Alabama at Birmingham	Phase 2